256 related articles for article (PubMed ID: 10188635)
1. Modulation of GABA release by dopamine in the substantia nigra.
Matuszewich L; Yamamoto BK
Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
[TBL] [Abstract][Full Text] [Related]
2. Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux.
Byrnes EM; Reilly A; Bruno JP
Synapse; 1997 Jul; 26(3):254-68. PubMed ID: 9183815
[TBL] [Abstract][Full Text] [Related]
3. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
[TBL] [Abstract][Full Text] [Related]
4. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
[TBL] [Abstract][Full Text] [Related]
5. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
Starr M
J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
[TBL] [Abstract][Full Text] [Related]
6. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies.
Abarca J; Gysling K; Roth RH; Bustos G
Neurochem Res; 1995 Feb; 20(2):159-69. PubMed ID: 7783840
[TBL] [Abstract][Full Text] [Related]
7. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
8. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
9. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat.
Grobin AC; Deutch AY
J Pharmacol Exp Ther; 1998 Apr; 285(1):350-7. PubMed ID: 9536031
[TBL] [Abstract][Full Text] [Related]
11. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
12. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
[TBL] [Abstract][Full Text] [Related]
13. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
[TBL] [Abstract][Full Text] [Related]
14. Electrical stimulation of the substantia nigra reticulata: detection of neuronal extracellular GABA in the ventromedial thalamus and its regulatory mechanism using microdialysis in awake rats.
Timmerman W; Westerink BH
Synapse; 1997 May; 26(1):62-71. PubMed ID: 9097406
[TBL] [Abstract][Full Text] [Related]
15. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
Carlson JH; Bergstrom DA; Weick BG; Walters JR
Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
[TBL] [Abstract][Full Text] [Related]
16. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
Ruskin DN; Rawji SS; Walters JR
J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra.
Hatzipetros T; Yamamoto BK
Brain Res; 2006 Mar; 1076(1):60-7. PubMed ID: 16680828
[TBL] [Abstract][Full Text] [Related]
19. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
Kelland MD; Freeman AS; Chiodo LA
Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
[TBL] [Abstract][Full Text] [Related]
20. D4 and D1 dopamine receptors modulate [3H] GABA release in the substantia nigra pars reticulata of the rat.
Acosta-García J; Hernández-Chan N; Paz-Bermúdez F; Sierra A; Erlij D; Aceves J; Florán B
Neuropharmacology; 2009 Dec; 57(7-8):725-30. PubMed ID: 19715708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
